The Growing Demand for Science-Backed Leadership in Supplements

Supplement buyers have started asking for proof. That is changing who brands need to hire. Thorne surveyed 3,013 US consumers. The top must-have was products backed by clinical research and scientific evidence, named by 37 percent. Clear ingredient labeling and clean ingredients came next, each at 33 percent. Evidence now outranks both. A brand cannot answer that with better copywriting. The proof has to exist before the claim does. That pushes science from a back-office job into the leadership team. This article covers what buyers want, why it changes who you hire, which roles brands are adding, and how to fill them.

What Are Supplement Buyers Actually Asking For?

Verification they can check, rather than promises on a label.

What Buyers Want	Finding	Source
Clinical research behind the product	Top must-have, named by 37 percent	Thorne consumer survey of 3,013 US adults
Clear ingredient labeling	Named by 33 percent	Thorne
Clean, pure ingredients	Named by 33 percent	Thorne
A quality or certification mark	More than 40 percent actively look for one	INFORMED survey conducted by CIL, UK and US
Transparency before purchase	Nearly half walked away from a supplement that lacked it	The Vitamin Shoppe 2026 Health and Wellness Trends Report
Trademarked over generic ingredients	Two-thirds trust them more, linking them to scientific validation	The Vitamin Shoppe

Read those together and a pattern appears. Buyers are not asking brands to sound more scientific. They want signals they can check themselves, which is a much harder request.

The confusion is real too. Nearly a third of Thorne’s respondents said health information from test results and medical history is too hard to read. That is an opening for brands that explain evidence clearly, and a risk for those that overstate it.

Why Does This Change the Leadership Requirement?

Because evidence cannot be bought late in the process.

A clinical study takes money, time, and design choices made long before a product launches. Someone has to pick which ingredient to study, at what dose, in which group, and against what measure. Those are scientific calls with commercial consequences. They get made years ahead of the campaign that depends on them.

That shapes structure. A company that buys its science from suppliers can only make claims those suppliers have already proven. A company with its own scientific leadership can build a claim nobody else owns.

It also protects the brand. Marketing that outruns the evidence is the fastest route to a regulatory problem. We covered that in Why Marketing Leadership in Health and Nutrition Requires Industry Expertise. A senior scientist in the room before a campaign is designed prevents most of it.

Which Scientific Roles Are Supplement Companies Adding?

Several that barely existed in this category fifteen years ago.

Role	What They Own	Where the Talent Comes From
Chief scientific officer	Research agenda, ingredient strategy, evidence standards	Pharma, biotech, academia, large CPG
Clinical affairs lead	Study design, trial partners, publication strategy	Contract research organizations, pharma clinical teams
Medical affairs lead	Practitioner education, scientific communication	Pharma medical affairs, clinical practice
Scientific and regulatory substantiation	Claim support dossiers, structure-function boundaries	Regulatory affairs in food, drug, or device
Analytical and quality leadership	Identity testing, potency, contaminant control	Laboratory services, manufacturing quality
Scientific advisory management	Advisory board, external researchers, credibility	Academia, clinical research

The medical affairs role shows how far the category has moved. It exists to speak to clinicians in their own language, a job supplement brands once had no reason to staff.

Why Is This Talent Hard to Attract?

Because most of it sits in industries that pay and work differently.

The people who can design a credible trial mostly trained in pharma, biotech, academia, or contract research. Moving one of them into a supplement company asks them to accept several changes at once.

• Faster commercial timelines than clinical development allows for.
• Smaller research budgets than they are used to proposing.
• A regulatory framework that permits structure-function claims rather than drug claims, which some find frustrating.
• Scepticism from former colleagues about the category’s scientific seriousness.
• Publication expectations that may conflict with commercial confidentiality.

None of that is fatal. Many scientists find the work faster and the impact easier to see than in drug development. But the pitch has to name those differences rather than pretend they are not there.

How Should Companies Hire for Scientific Leadership?

Six steps that improve the odds.

1. Decide what the science is for. Backing existing claims, setting a hero product apart, and building a research pipeline need different people. A clear position profile built on that decision prevents a mismatched hire.
2. Hire the senior scientist before the studies. Hiring someone to run trials a supplier already designed wastes most of their value.
3. Test commercial fluency. Ask a candidate how they would choose between two study designs when one is faster and the other more defensible. Listen for whether they weigh both.
4. Be honest about budget and speed. Scientists who learn the real limits after joining tend to leave. Those who accepted them up front tend to stay.
5. Offer scientific standing. Publication rights, conference presence, and advisory board seats cost little and matter more than most employers expect.
6. Reach people who are not looking. Senior scientists rarely browse job boards. Retained executive search is built to approach them directly and privately.

Sector knowledge shortens the work, because a sports nutrition brand and a clinical nutrition company need different scientific backgrounds. Matching that correctly is part of human health and nutrition executive search.

Final Thoughts

The supplement category is growing up, and buyers are driving it. Clinical evidence is now the single thing they most want to see. More than 40 percent look for a certification mark, and nearly half have put a product back on the shelf for lack of transparency. Those are buying behaviors, not opinions. They reward companies that can prove what they say.

Proof is built years before it is used. That is why science has moved into the leadership team rather than staying in a lab. The brands pulling ahead have a senior scientist shaping which products get built and which claims are worth chasing. Not reviewing the copy at the end.

The Carlisle Group recruits scientific, clinical, regulatory, and quality leadership across the human health and nutrition sector. If you are building scientific depth into your leadership team, tell us what you need to prove and we will build the search around it.